Marylène Lejeune

Mrs. Marylène Lejeune

Pathology department, Hospital de Tortosa Verge de la Cinta, Tortosa, Spain
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2005 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
TATomás ÁlVaro
Tomás ÁlVaro
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
MSMa Teresa Salvadó
Ma Teresa Salvadó
RPRamon Bosch Príncep
Ramon Bosch Príncep
JGJuan F. García
Juan F. García
Miguel PirisMiguel Piris
Miguel Piris
Purpose: Recent studies of Hodgkin's lymphoma (HL) have suggested that the presence of regulatory T cells in the reactive background may explain the inhibition of the antitumoral host immune response observed in these patients. This study aimed to assess the relevance of regulatory T cells and CTLs present in the background of HL samples in the prognosis of a series of classic HL (cHL) patients. Experimental Design: Expression of granzyme B and TIA-1 (markers for CTL) and FOXP3 (a marker for regulatory T cells) were evaluated independently by immunohistochemistry in tissue microarrays of 257 cHL patients and correlated with patient outcome. Results: The combined influence of the presence of FOXP3+ and TIA-1+ cells distinguished three risk groups of patients with 5-year overall survival of 100%, 88%, and 73%. The presence of a small number of FOXP3+ cells and a high proportion of TIA-1+ cells in the infiltrate represent an independent prognostic factor that negatively influenced event-free survival and disease-free survival in cHL. Compared with the features at diagnosis, relapsed samples tended to have more TIA-1+ cells and a lower proportion of FOXP3+ cells in the reactive background. Conclusions: These data suggest that low infiltration of FOXP3+ cells in conjunction with high infiltration of TIA-1+ cells in cHL may represent biological markers predicting an unfavorable outcome. Moreover, the variation of these markers over the course of the disease implies a possible role for them in the progression of HL cases.

1 December 2006 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
TÁTomás Álvaro
Tomás Álvaro
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
MSMaria-Teresa Salvadó
Maria-Teresa Salvadó
CLCarlos López
Carlos López
JJJoaquín Jaén
Joaquín Jaén
LPLluis E. Pons
Lluis E. Pons
Purpose: Recent molecular data have suggested that non-neoplastic cells are powerful modulators that may confer a selective advantage or disadvantage on the outcome of follicular lymphoma (FL) patients.Patients and Methods: The prevalence of the principal inflammatory and immune-infiltrated cells was measured immunohistochemically in the tissue of 211 FL patients, and associations were sought with their traditional clinicobiologic characteristics.Results: Our results confirmed the presence of a large number of T lymphocytes (CD4+and CD8+) and CD57+cells and, at a moderate level, the presence of TIA-1+cytotoxic cells, CD68+macrophages, CD123+plasmacytoid cells, and FOXP3+regulatory T cells among the pool of non-neoplastic cells. In addition to the conventional clinical variables, univariate analysis identified a low level of infiltrated CD8+T lymphocytes as a significantly negative prognostic factor of overall survival. The following significant differences in the abundance of cells of specific and nonspecific immunity were observed in relation to the clinicobiologic features of FL: (1) a reactive microenvironment mainly made up of T lymphocytes and macrophages was significantly associated with a favorable clinical behavior of FL patients; and (2) a reactive microenvironment infiltrated predominantly by CD57+T cells was associated with a significantly higher frequency of adverse clinicobiologic manifestations such as “B” symptoms and bone marrow involvement.Conclusion: Our results demonstrate the existence of two specific patterns in the reactive microenvironment of FL, an immunosurveillance pattern (T lymphocytes and macrophages) and an immune-escape pattern (CD57+T cells), that were directly associated with the clinicobiologic features of these patients.

27 June 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RPR. Pacheco
R. Pacheco
JMJ. M. Martinez-Navio
J. M. Martinez-Navio
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
Núria ClimentNúria Climent
Núria Climent
HOH. Oliva
H. Oliva
Rafael FrancoRafael Franco
Rafael Franco
Adenosine deaminase (ADA), a protein whose deficit leads to severe combined immunodeficiency, binds to the cell surface by means of either CD26, A1adenosine receptors, or A2Badenosine receptors. The physiological role of these interactions is not well understood. Our results show that by a 3-fold reduction in the EC50for the antigen, ADA potentiated T cell proliferation in autologous cocultures with antigen-pulsed immature or mature dendritic cells. Costimulation was not due to the enzymatic activity but to the interaction of ADA–CD26 complexes in T cells with an ADA-anchoring protein in dendritic cells. From colocalization studies, it is deduced that ADA colocalizing with adenosine receptors on dendritic cells interact with CD26 expressed on lymphocytes. This costimulatory signal in the immunological synapse leads to a marked increase (3- to 34-fold) in the production of the T helper 1 and proimmflamatory cytokines IFN-γ, TNF-α, and IL-6.

1 October 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAlex Soriano
Alex Soriano
CMCatalina Martínez
Catalina Martínez
FGFelipe García
Felipe García
MPMontserrat Plana
Montserrat Plana
EPEduard Palou
Eduard Palou
TGTeresa Gallart
Teresa Gallart
Plasma stromal cell–derived factor (SDF)-1 levels, SDF1-3′A polymorphism, and CXCR4+ T lymphocytes in relation to resistance to human immunodeficienc

1 November 2005 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
TÁTomás Álvaro-Naranjo
Tomás Álvaro-Naranjo
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
MSMaria T. Salvadó-Usach
Maria T. Salvadó-Usach
RPRamon Bosch Príncep
Ramon Bosch Príncep
GRGemma Reverter-Branchat
Gemma Reverter-Branchat
LPLluis E. Pons-Ferré
Lluis E. Pons-Ferré
The present study aimed to describe the general tissular composition of the immune infiltrate observed in Hodgkin's lymphoma (HL) and its possible relationship with clinical and survival prognostic factors. In this retrospective study of 267 HL patients, the relative proportions of infiltrating T lymphocytes (CD4 + , CD8 + ), natural killer cells (CD56 + , CD57 + ), cytotoxic cells (Granzyme B + , TIA-1 + ) and dendritic cells (CD21 + , S-100 + ) were quantified immunohistochemically with tissue microarray technology. Our results confirm the predominance of CD4 + T lymphocytes in the background of tumoral cells, in addition to a high number of cytotoxic lymphocytes (CD8, CD57 and TIA-1). Patients with low numbers of infiltrating CD8, CD56, CD57 + cells and high numbers of Granzyme B and TIA-1 + cells presented a significantly unfavourable clinical course (presence of leukocytosis, B symptoms, advanced clinical stage (III/IV), non-responding patients). A reduced infiltration of CD4 + T lymphocytes was related with the presence of Epstein – Barr virus. Significantly longer survival times were observed in patients with a high level of infiltrating CD57, as well as a low level of Granzyme B and TIA-1 + cells (log-rank test). When evaluated in a multivariate model, high levels of infiltrating TIA-1 and Granzyme B + cells were shown to be independent prognostic factors that negatively influenced overall survival. The presence of TIA-1 + cells was found to be the only unfavorable prognostic factor of event-free survival and disease-free survival. The overall detection of tumor-infiltrating cells in HL confirms the importance of cytotoxic T lymphocyte infiltration (Granzyme B and TIA-1 + cells) in these patients. Independently of the classical clinical and pathological features, these cells appear to be an unfavourable prognostic factor in HL and, more particularly, the presence of cytotoxic TIA-1 + cells.

28 May 2008 in Journal of Anatomy
Verified
Journal Article
Closed access
PDF file
Marylène LejeuneMarylène Lejeune
Marylène Lejeune
JJJoaquín Jaén
Joaquín Jaén
LPLluis Pons
Lluis Pons
CLCarlos López
Carlos López
MSMaria‐Teresa Salvadó
Maria‐Teresa Salvadó
TÁTomás Álvaro
Tomás Álvaro